Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Endocr Relat Cancer. 2019 Aug;26(8):699–712. doi: 10.1530/ERC-19-0188

Fig. 1. Effects of group I PAK inhibition on cell viability.

Fig. 1.

A panel of eight thyroid cancer cell lines was treated with increasing doses of G-5555 or FRAX1036 for 72 hours. Cell viability was determined by colorimetric WST-8 assay. The optical density of each treatment was normalized to the 0 μM control. Assays were conducted in triplicate with at least three biological replicates. Data are represented as means ± SD.